Is current evidence about intraoperative partial breast irradiation sufficient for broad implementation in clinical practice?
Division of Oncology, Rambam Health Care Campus, Haifa, Israel. Electronic address: o_person@rambam.health.gov.il.
O
O
Kaidar-Person
Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. Electronic address: john.yarnold@icr.ac.uk.
J
J
Yarnold
Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: bvo@oncology.dk.
B V
BV
Offersen
Institute Verbeeten, Tilburg, The Netherlands. Electronic address: poortmans.ph@bvi.nl.
P
P
Poortmans
D001918:Brachytherapy / Q000379:methods; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015994:Incidence; D007430:Intraoperative Care / Q000379:methods*; D008408:Mastectomy / Q000379:methods; D015412:Mastectomy, Segmental / Q000379:methods; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D011379:Prognosis; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome